ETH Zurich Foundation, Dicronis


Patrizia Marschalkova

Fluorescent microneedles for a measure of the dermal lymphatic function

Dicronis develops diagnostic and therapeutic products for diseases with high unmet medical needs. The first product in their pipeline, Lymphit, allows for remote tracking of lymphatic activity. The technology employs microneedles for the painless transdermal delivery of a fluorescent agent and measure of its uptake using a wearable device, in a simple, home-based and highly-scalable manner. Among others, this is useful for the early diagnosis of lymphedema, a chronic, progressive and debilitative complication of cancer therapies.

More on Dicronis in the ETH news and on their website.